Tasos Konidaris - Mar 3, 2025 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Signature
/s/ Denis Butkovic, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
Mar 3, 2025
Transactions value $
-$1,367,545
Form type
4
Date filed
3/5/2025, 07:53 PM
Previous filing
Mar 4, 2025
Next filing
Mar 7, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise +45.3K +8.23% 595K Mar 3, 2025 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability -$143K -16.4K -2.75% $8.76 579K Mar 3, 2025 Direct F3
transaction AMRX Class A Common Stock Options Exercise +57.3K +9.9% 636K Mar 3, 2025 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability -$214K -24.4K -3.83% $8.76 612K Mar 3, 2025 Direct F3
transaction AMRX Class A Common Stock Options Exercise +181K +29.61% 793K Mar 3, 2025 Direct F4
transaction AMRX Class A Common Stock Tax liability -$812K -92.7K -11.68% $8.76 700K Mar 3, 2025 Direct F5
transaction AMRX Class A Common Stock Options Exercise +44K +6.28% 744K Mar 4, 2025 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability -$199K -22.5K -3.02% $8.84 722K Mar 4, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Restricted Stock Units Options Exercise $0 -45.3K -50% $0.00 45.3K Mar 3, 2025 Class A Common Stock 45.3K Direct F2, F6
transaction AMRX Restricted Stock Units Options Exercise $0 -57.3K -33.33% $0.00 115K Mar 3, 2025 Class A Common Stock 57.3K Direct F2, F7
transaction AMRX Performance-Based Restricted Stock Units Options Exercise $0 -181K -100% $0.00 0 Mar 3, 2025 Class A Common Stock 181K Direct F4
transaction AMRX Performance-Based Restricted Stock Units Award $0 +228K $0.00 228K Mar 3, 2025 Class A Common Stock 228K Direct F8, F9
transaction AMRX Restricted Stock Units Award $0 +114K $0.00 114K Mar 3, 2025 Class A Common Stock 114K Direct F2, F10
transaction AMRX Restricted Stock Units Options Exercise $0 -44K -25% $0.00 132K Mar 4, 2025 Class A Common Stock 44K Direct F2, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F3 Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
F4 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5.
F5 Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.
F6 On March 3, 2022, the reporting person was granted 181,159 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
F7 On March 3, 2023, the reporting person was granted 229,358 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
F8 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F9 Represents a performance-based restricted stock unit grant of 114,155 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2028, the last day of the performance period.
F10 The restricted stock units vest in four equal annual installments beginning on March 3, 2026.
F11 On March 4, 2024, the Reporting Person was granted 175,926 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.